@article{4ce18e16720645c8ac954d1dae55c244,
title = "Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice",
abstract = "Injection drug use is the most common transmission route for hepatitis C. High rates of infection are observed among individuals on opioid agonist therapy. Although people who inject drugs carry the highest burden, few have initiated treatment. We present a comprehensive review of the evidence on the efficacy of HCV medications, drug–drug interactions, and barriers to and models of care. Studies have demonstrated comparable efficacy for individuals who are on opioid agonist therapy compared with those who are not. We propose that a strategy of treatment and cure-as-prevention is imperative in this population to curb the hepatitis C epidemic.",
keywords = "Best practice, Direct acting antivirals, Drug-drug interactions, Hepatitis C virus, Opioid agonist therapy",
author = "Norton, {Brianna L.} and Akiyama, {Matthew J.} and Zamor, {Philippe J.} and Litwin, {Alain H.}",
note = "Funding Information: Disclosure: A.H. Litwin has served on the advisory board of Abbvie, BMS, Gilead Sciences, and Merck. P.J. Zamor has served on the speakers bureau for Gilead, AbbVie, Merck, and Bristol Myers Squibb, and on the advisory board for Gilead, AbbVie, and Bristol Myers Squibb. M.J. Akiyama has been the recipient of a Gilead Investigator Sponsored Research Grant. B.L. Norton has no conflicts of interest. This review was funded in part by NIDA K23DA039060, NIDA K24DA036955, and NIDA R01 DA034086. Funding Information: Disclosure: A.H. Litwin has served on the advisory board of Abbvie, BMS, Gilead Sciences, and Merck. P.J. Zamor has served on the speakers bureau for Gilead, AbbVie, Merck, and Bristol Myers Squibb, and on the advisory board for Gilead, AbbVie, and Bristol Myers Squibb. M.J. Akiyama has been the recipient of a Gilead Investigator Sponsored Research Grant. B.L. Norton has no conflicts of interest. This review was funded in part by NIDA K23DA039060 , NIDA K24DA036955 , and NIDA R01 DA034086 . Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",
year = "2018",
month = jun,
doi = "10.1016/j.idc.2018.02.001",
language = "English (US)",
volume = "32",
pages = "347--370",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "2",
}
